Compare PepsiCo, Inc. (PEP) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PepsiCo, Inc. vs Viatris Inc — how do they compare? PepsiCo, Inc. trades at $135.86 (market cap $184.26B), while Viatris Inc trades at $17.02 (market cap $20.50B). The key difference: PepsiCo, Inc. is far larger — about 9× Viatris Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.39%). Which is the better fit depends on your goals.
| PEP | VTRS | |
|---|---|---|
Market Cap | $184.26B | $20.50B |
Sector | Consumer Staples | Health |
52-Week High | $170.44 | $17.59 |
52-Week Low | $134.98 | $8.74 |
Enterprise Value | $226.76B | $32.71B |
Dividend Yield | 4.39% | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $135.65, showing minimal daily movement with a slight 0.14% gain. The technical outlook is bearish per moving averages, while fundamentals reflect steady revenue near $94B and strong profitability with a 10.78% net margin. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, alongside ongoing North American recovery efforts ahead of Q1 2026 earnings.
The stock presents a mixed outlook: analyst consensus leans hold (64% of ratings) with a $158.79 price target suggesting upside, but risks include margin pressure from pricing strategies and volatile cash flows. Institutional activity shows mixed signals, with some firms increasing stakes while others reduce holdings, indicating cautious optimism amid competitive and consumer sentiment challenges.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
